# Maternal-Fetal Medicine Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Cleopatra (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-AC003-SYN
- Date: 2026-03-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Samira Haddad-Thornbury, MD
- Calendar frame: modern shifted

- Requested by: Nefeli Arvanitis-Osei, MD

## Reason for consultation

Second pregnancy at 9 weeks by a certain last menstrual period, with the uterus about 12 to 13 weeks in size and heavier nausea than in her first pregnancy. Please perform a first-trimester ultrasound at 11 weeks to establish the dates and the cause of the large uterus, and advise on her prenatal care. **S**

## History

Cleopatra is seen at the request of Dr. Arvanitis-Osei at 11 weeks 0 days. Her first pregnancy, seven years ago, went to term without complications, by her account, with a vaginal birth. She has regular cycles and a certain last period. Nausea has eased on doxylamine with pyridoxine. No bleeding or pain. No family history of twins that she knows of and no fertility treatment. She leads a demanding business and wants to keep working; she prefers clear plans and women clinicians. **S**

## Examination

| System | Finding |
|---|---|
| General | Well |
| Abdomen | Uterus about 14 weeks in size; non-tender |
| Ultrasound | Two fetal hearts, 162 and 158 per minute |

BP 106/64 mmHg; pulse 86 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 58.2 kg; BMI 21.4 kg/m². All vital signs are synthetic.

## Data reviewed

Today's first-trimester ultrasound: two live intrauterine fetuses; a thick dividing membrane meeting a fused anterior placental mass in a twin-peak (lambda) sign; crown-rump lengths 45 mm (11 weeks 2 days) and 46 mm (11 weeks 3 days); nuchal translucency 1.6 and 1.8 mm; nasal bones present; no structural abnormality seen; no fibroids; normal ovaries; no features of a molar pregnancy. First-visit tests: hemoglobin 10.8 g/dL, MCV 79 fL, ferritin 14 ng/mL; hCG 152,000 mIU/mL; blood group A RhD positive, antibody screen negative; rubella immune; hepatitis B, HIV, syphilis, and hepatitis C negative; urine culture no growth. Today's blood pressure 106/64 mmHg and weight 58.2 kg. Crown-rump length, twin A: 45 mm; Crown-rump length, twin B: 46 mm; Nuchal translucency, twin A: 1.6 mm; Nuchal translucency, twin B: 1.8 mm. All results are synthetic.

## Assessment

1. **Uterus larger than dates** (O26.841). Explained by a twin pregnancy. Her dates stand: the crown-rump lengths differ from her last period by three days or less, within the seven days that would call for redating before 14 weeks. No fibroids or molar features, and the hCG fits twins. **S**
2. **Twin pregnancy, dichorionic diamniotic** (O30.041). Dichorionic diamniotic by the twin-peak sign and the thick membrane, determined before 14 weeks, when the assessment is most accurate. Dichorionic twins avoid twin-to-twin transfusion but carry higher risks of preterm birth, preeclampsia, growth restriction and discordance, gestational diabetes, anemia, and postpartum hemorrhage than a single pregnancy. **S**
3. **Iron deficiency anemia in pregnancy** (O99.011). Iron needs are higher with twins; oral iron should be tried first and checked in the second trimester. **S**

## Recommendations

1. Aneuploidy screening: nuchal translucency for each twin, done today, with cell-free DNA, drawn today as she chose; in twins cell-free DNA cannot say which twin is affected and fails more often. Chorionic villus sampling or amniocentesis remain available.
2. Low-dose aspirin 81 mg at bedtime from 12 weeks until delivery, because a twin pregnancy is a high-risk factor for preeclampsia; blood pressure and urine protein at every visit.
3. Continue ferrous sulfate every other day; check the blood count and ferritin at the anatomy-scan visit and give intravenous iron in the second trimester if they do not improve.
4. Detailed anatomy scans of both twins at 18 to 22 weeks with placental location and a transvaginal cervical length; then growth scans every four weeks with the discordance calculated; a discordance of 20 percent or more, or a twin below the 10th centile, would need closer review.
5. Preterm birth: teach the warning signs; do not use cerclage, a pessary, progesterone, or bed rest for a twin pregnancy alone; antenatal corticosteroids if birth before 34 weeks is threatened.
6. Gestational diabetes screen at 24 to 28 weeks; weight gain of about 17 to 25 kg; visits every two to four weeks, every two weeks from 28 weeks.
7. Plan birth at 38 0/7 to 38 6/7 weeks in a hospital with a neonatal intensive care unit if the pregnancy stays uncomplicated; weekly fetal testing may be considered from 36 weeks; the mode of birth depends on the presentation of twin A, to be decided in the third trimester.
8. EPDS in each trimester and after the birth.

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Communication

Discussed with Dr. Arvanitis-Osei the same day. Cleopatra agrees with the plan and chose cell-free DNA screening today. **S**

## Follow-up

Primary obstetric care continues with Dr. Arvanitis-Osei. Maternal-fetal medicine will perform the anatomy and growth scans and review any discordance, and will see her again before the birth. **S**

## Guideline basis

- Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231 (2021), American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine (Obstetrics & Gynecology)
- Medically Indicated Late-Preterm and Early-Term Deliveries: ACOG Committee Opinion, Number 831 (2021), American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine (Obstetrics & Gynecology)
- Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234 (2021), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Committee Opinion No 700: Methods for Estimating the Due Date (2017), American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, and Society for Maternal-Fetal Medicine (Obstetrics & Gynecology)
- Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Anemia in Pregnancy: ACOG Practice Bulletin, Number 233 (2021), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021), U.S. Preventive Services Task Force
- ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus (2018), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
- Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 4 (2023), American College of Obstetricians and Gynecologists (Obstetrics & Gynecology)
